Skip to main content
. 2014 Oct 4;16(3):299–308.

Fig 2.

Fig 2

Comparison of different doses of silybin, and silybin-phosphatidylcholine after 24 (A), 48 (B), and 72 hours (C) of treatment. Data is presented as percentage of viability in three independent experiments. *; p< 0.05, **; p<0.01 and ***; p< 0.001.